Orexigen Therapeutics IncNASDAQ:OREX

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the UBS Global Healthcare Conference in New York. The presentation is scheduled for Wednesday, May 22nd at 11 a.m. Eastern Time. To l...

Levi & Korsinsky, LLP is investigating Orexigen Therapeutics, Inc. (NasdaqGS: OREX), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

To get more information, click here: htt...

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas. The presentation is scheduled for Wednesday, May 15th at ...

Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter ended March 31, 2013.

For the three months ended March 31, 2013, Orexig...

Levi & Korsinsky, LLP is investigating Orexigen Therapeutics, Inc. (NasdaqGS: OREX), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84...

Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will announce financial results for the first quarter ended March 31, 2013, on Wednesday, May 8, 2013 after the markets close. The ann...

New York (April 26th, 2013) - Radian Group Inc. (NYSE: RDN) CEO, S.A. Ibrahim, and Radian Guaranty, President Teresa Bryce Bazemore, were recently asked to speak at two well-regarded mortgage industry events.